Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) CFO Thomas Catinazzo sold 1,800 shares of Relay Therapeutics stock in a transaction that occurred on Thursday, April 9th. The shares were sold at an average price of $15.00, for a total value of $27,000.00. Following the completion of the transaction, the chief financial officer owned 213,867 […]

Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) CFO Thomas Catinazzo sold 1,800 shares of the firm’s stock in a transaction dated Thursday, April 9th. The shares were sold at an average price of $15.00, for a total value of $27,000.00. Following the completion of the sale, the chief financial officer owned 213,867 shares of […]

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) insider Amy Simon sold 6,700 shares of Beam Therapeutics stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $24.58, for a total transaction of $164,686.00. Following the completion of the sale, the insider owned 102,735 shares of […]

Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) CEO Alfred Sandrock sold 11,511 shares of Voyager Therapeutics stock in a transaction on Thursday, April 2nd. The stock was sold at an average price of $3.87, for a total transaction of $44,547.57. Following the completion of the sale, the chief executive officer owned 472,549 shares of […]

Tectonic Therapeutic, Inc. (NASDAQ:TECX – Get Free Report) insider Marcella Ruddy sold 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $31.05, for a total value of $31,050.00. Following the completion of the sale, the insider directly owned 68,747 shares […]

Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) CFO Scott Burrows sold 7,500 shares of the company’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $49.34, for a total transaction of $370,050.00. Following the completion of the transaction, the chief financial officer owned 97,994 shares in […]

Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) Director Daphne Karydas sold 3,000 shares of Mineralys Therapeutics stock in a transaction dated Tuesday, March 31st. The shares were sold at an average price of $25.00, for a total value of $75,000.00. Following the completion of the sale, the director owned 6,200 shares of the company’s […]

Maze Therapeutics, Inc. (NASDAQ:MAZE – Get Free Report) CMO Harold Bernstein sold 15,000 shares of the firm’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $29.46, for a total value of $441,900.00. Following the completion of the transaction, the chief marketing officer owned 15,000 shares of […]

Capricor Therapeutics, Inc. (NASDAQ:CAPR – Get Free Report) Director Karimah Es Sabar sold 61,265 shares of the stock in a transaction dated Tuesday, March 31st. The stock was sold at an average price of $30.17, for a total transaction of $1,848,365.05. The sale was disclosed in a filing with the SEC, which can be accessed […]

Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) insider Adam Crystal sold 12,000 shares of Tango Therapeutics stock in a transaction that occurred on Wednesday, March 25th. The shares were sold at an average price of $20.11, for a total transaction of $241,320.00. Following the sale, the insider owned 112,622 shares in the company, valued […]